All Episodes

E214 - Therapeutic Guidelines Kidney and Urinary

E213 - Metabolic dysfunction–associated fatty liver disease an update

E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals

E211 - Preventing infections in immunosuppressed patients

E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective?

E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline

E208 - Pharmacological management of attention deficit hyperactivity disorder in adults

E207 - Injectable drugs for weight management

E206 - Testing for human immunodeficiency virus

E205 - Top 10 drugs 2024-25

E204 - Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism

E203 - Pharmacological management of attention deficit hyperactivity disorder in children and adolescents

E202 - Gestational diabetes update on screening, diagnosis and maternal management

E201 - Practical guidance for stopping glucocorticoids

E200 - Therapeutic Guidelines Oral and Dental update

E199 - Aminoglycosides: an update on indications, dosing and monitoring

E198 - Choosing a nonsteroidal anti-inflammatory drug for pain

E197 - Potentially inappropriate medicines for older people

E196 - Male and female pattern hair loss

E195 - Medicines used in the treatment of opioid dependence

E194 - Using pharmacogenomics to personalise drug therapy

E193 - Therapeutic Guidelines Antibiotic Part 2

E192 - Update on long- and short-acting contraceptive methods

E191 - Psoriasis an update on topical and systemic therapies

E190 - Safe and effective use of vancomycin

E189 - Noninvasive prenatal testing: an overview

E188 - RSV: an update on prevention and management

E187 - Therapeutic Guidelines Antibiotic Part 1

E186 - Calcitonin gene-related peptide–targeted therapies for migraine

E185 - The role of triple antithrombotic therapy in patients with atrial fibrillation and coronary stent insertion

E184 - Device-assisted therapies for Parkinson disease

E183 - Drug safety in pregnancy

E182 - A national standard for people living with chronic obstructive pulmonary disease

E181 - Adverse drug reactions reporting

E180 - Diagnosis and management of antiphospholipid syndrome

E179 - Therapeutic vapes for smoking cessation and nicotine dependence

E178 – Reflections on community antimicrobial prescribing in Australia

E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease

E176 - Managing medicine shortages

E175 - Pharmacological management of polycystic ovary syndrome

E174 - Achieving safe medication management during transitions of care from hospital

E173 - Management of occupational exposure to blood and body fluids in primary care

E172 - Utility of common investigations for suspected inflammatory arthritis in adults

E171 - Controversies in the management of community-acquired pneumonia in adults

E170 - Quality use of medicines: who owns it now?

E169 - Deprescribing antihypertensives in frail older adults

E168 - New and emerging drug therapies for Alzheimer disease

E167 - Diagnosis and management of obstructive sleep apnoea in adults

E166 - Biologic therapies for severe asthma with persistent type 2 inflammation

E165 - Assessing, communicating and managing cardiovascular disease risk

E164 - Diagnosis and management of eosinophilic oesophagitis

E163 - Managing pre-existing diabetes prior to and during pregnancy

E162 - Management of menopause symptoms

E161 - Managing hypercholesterolaemia

E160 - Ongoing challenges of off-label prescribing

E159 - Therapeutic Guidelines Dermatology

E158 - National Medicines Policy 2.0

E157 - Top 10 drugs 2021-22 and 2022-23

E156 - Physical health monitoring for people with schizophrenia

E155 - Digital health and prescribing

E154 - An update on wound management

E153 - Blood glucose monitoring devices

E152 - Therapeutic Guidelines Diabetes

E151 - COVID-19 vaccines in 2023

E150 - COVID-19 testing: a 2023 update

E149 - Treatments for atopic dermatitis

E148 - Medicines stewardship

E147 - Therapeutic Guidelines Addiction

E146 - Medicines and children

E145 – Australian Asthma Handbook update

E144 – Therapeutic Guidelines Gastrointestinal

E143 – Treating osteoporosis

E142 – Rheumatic fever and heart disease

E141 – Polycystic kidney disease

E140 – How to manage erectile dysfunction

E139 – SGLT2 inhibitors for kidney and heart disease

E138 – Therapeutic Guidelines Sore Throat

E137 – Stepping down asthma preventer treatment

E136 – Imaging of patients with headaches

E135 - Therapeutic Guidelines Wilderness Medicine

E134 - Hormonal contraception and mood disorders

E133 – Prescribing for patients on antiretrovirals

E132 – Making guidelines better

E131 – Drugs for the management of obesity

E130 – Severe cutaneous adverse drug reactions

E129 – Home oxygen therapy

E128 – COVID-19 oral antivirals

E127 – Chronic non-cancer pain in older people

E126 - Cluster headache

E125 - How to quit smoking

E124 - Therapeutic Guidelines Psychotropic

E123 - Top 10 drugs 2020–21

E122 - Medical abortion in primary care

E121 – Iron deficiency without anaemia

E120 – Therapeutic Guidelines Developmental Disability

E119 – The problems with fluoroquinolones

E118 – Pharma sponsorship of health consumer groups

E117 – Hypertension in pregnancy

E116 – Vitamins and minerals: how safe are they?

E115 – Therapeutic Guidelines Liver Disorders

E114 - Rational prescribing: where are we now?

E113 – Managing insomnia in primary care

E112 – Ocular effects of oral drugs

E111 – Therapeutic Guidelines Pain and Analgesia

E110 – Drugs for secondary stroke prevention

E109 – Updated anaphylaxis guidelines

E108 – Opioid and antidepressant combinations

E107 – Hepatitis C elimination

E106 – eTG Sexual and reproductive health guidelines

E105 – Naloxone for opioid toxicity and overdose

E104 – Anticoagulation in atrial fibrillation

E103 – Speaking of statistical significance

E102 – eTG Respiratory guidelines

E101 – Managing pain after surgery

E100 – COVID-19 vaccination in Australia

E99 – How to choose an antidepressant

E98 – Autism treatment

E97 – Harms and benefits of SGLT2 inhibitors

E96 – Vulvovaginitis

E95 – Migraine management

E94 – HIV diagnoses fall as PrEP is embraced

E93 – Prescription monitoring and helping people at risk

E92 – Testing for COVID-19

E91 - Opioid prescribing in dentistry

E90 - What is hypertension?

E89 - Prescribing medicinal cannabis

E88 – Managing chronic leukaemias

E87 – Potions and the dark arts – the latest from eTG Toxicology

E86 - Deprescribing in older people

E85 - Managing autoimmune disease during the pandemic

E84 – Managing proteinuria

E83 - Dental pain management in primary care

E82 – Immunosuppression for COVID-19

E81 - Paediatric penicillins – getting the dose right

E80 – Prescribing antiemetics

E79 – COVID-19 and the quality use of medicines

E78 – Oral or intravenous antibiotics

E77 - Ethical prescribing, hydroxychloroquine and COVID-19

E76 – Atrial fibrillation

E75 - Australian Prescriber and COVID-19

E74 – Faecal transplants

E73 – eTG Oral and dental guidelines

E72 – Shingles vaccination in Australia

E71 – Drug interaction resources: mind the gaps

E70 – Heart failure with preserved ejection fraction

E69 – eTG Antibiotic guidelines

E68 – Our National Medicines Policy needs a reboot

E67 – Penicillin allergy

E66 – Psychoactive drugs and driving

E65 – eTG Bone and metabolism guidelines

E64 - Antimicrobial use in aged care

E63 – Immunomodulatory drugs in pregnancy and lactation

E62 – Prescribing Skills Assessment

E61 – Dose adjustment in chronic kidney disease

E60 – Stopping and switching antipsychotic drugs

E59 – Ulcer and wound management guidelines

E58 – Blood pressure – when to treat?

E57 – Meningococcal vaccines

E56 – Safety of computerised prescribing in hospitals

E55 – Venous thromboembolism

E54 – Drug-induced movement disorders

E53 - Adolescent self-harm

E52 - Insulin pumps

E51 - Complementary medicines

E50 - Real-time prescription monitoring

E49 – Immune checkpoint inhibitors

E48 - My Health Record

E47 - Review of new eTG diabetes guidelines

E46 - Influenza: prevention and treatment

E45 – Old antibiotics for resistant UTIs

E44 – Prescribing for adolescents

E43 – Prescribing for transgender patients

E42 – Optimal antimicrobial duration

E41 – Top 10 drugs 2017–18

E40 - Alcohol detox at home

E39 – Perimenopausal depression

E38 – Unpronounceable drug names

E37 – Drugs for benign prostatic hypertrophy

E36 – Second steps in managing type 2 diabetes

E35 – Treatment of irritable bowel syndrome

E34 – Medical management of metastatic prostate cancer

E33 – Combining anticoagulation and antiplatelet drugs in coronary artery disease

E32 – Travelling with medicines

E31 – Infantile colic

E30 – Fast-tracking of new drugs

E29 – Neuropathic pain

E28 – A RUM deal for unwanted medicines

E27 – Common eye infections

E26 – Reducing medication errors at transitions of care

E25 – Antihistamines and allergy

E24 – Prescribing wellness: a better way to manage chronic pain

E23 - 'Cephalosporin allergy' label is misleading

E22 – Pharmacovigilance and expedited drug approvals

E21 – The cost of asthma medicines

E20 – Prescribing for polymyalgia rheumatica

E19 – Adverse effects of sports supplements in men

E18 – Drugs affecting milk supply during lactation

E17 – An update on the treatment of rosacea

E16 - Changes for codeine

E15 - Functional dyspepsia

E14 – Top 10 drugs 2016–17

E13 – Australian biters and stingers: the latest on antivenoms

E12 – Product familiarisation programs

E11 – Medication management on sick days

E10 – Surgical antimicrobial prophylaxis

E9 - Antibiotic prophylaxis for dental procedures

E8 – Treatment of fibromyalgia

E7 – Suicidality: prevention, detection and intervention

E6 – Encouraging adherence to long-term medication

E5 – Community use of naloxone for opioid overdose

E4 – Chronic heart failure

E3 – Immunisation and pregnancy

E2 – Changing Australian medicine names

E1 - Retail Genetics